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Summary
Under physiological conditions, the vast majority of T cellsdifferentiate in the thymus, an organ
that provides an optimal microenvironment for T cell maturation and shapes the T cell repertoire
via positive and negative selection processes. In the present report, we demonstrate that neonatal
thymectomy of CBA/H mice results in a diminution of T cells in peripheral lymphoid organs
(spleen, lymph nodes), but is followed by a marked transient (12 wk) increase in Thy-1+ CD3+
cells in the peritoneal cavity. These cells exhibit predominantly a double-negative (CD4 - CD8 - )
phenotype among which products of the T cell receptor (TCR) VO11 gene family (i.e., an I-E-
reactive TCR normally deleted in I-E-bearing CBA/H mice) are selectively overexpressed. This
observation suggests that, under athymic conditions, T cell differentiation and/or accumulation
may occur in the peritoneal cavity. Intraperitoneal inoculation of an interleukin 2 (IL2) vaccinia
virus construct that releases high titers of human IIr2 in vivo induces conversion of these double-
negative T cells to either CD4+CD8 - or CD4-CD8+ single positives, and allows in vitro
stimulation of TCR V,311-bearing cells with a clonotypic antiVO antibody. Since IL-2 induces
autoimmune manifestations (DNA autoantibodies, rheumatoid factors, and interstitial nephritis)
in thymectomized CBA/H mice, but not in sham-treated littermates, this lymphokine is likely
to enhance the autoaggressive function of T cells that bear forbidden, potentially autoreactive
TCR gene products and that are normally deleted in the thymus.
T
he mature T cell repertoire is known to be shaped by
both negative and positive selection events in the thymus
(1, 2). Albeit the designation "T cell" is due to the apparent
thymus dependence of T lymphocyte differentiation, an in-
creasing body of evidence indicates the possibility that T cell
precursors mature under extrathymic conditions. Thus, con-
genitally athymic (nude or nu/nu) mice, i.e., mutant strains
whose thymic anlage is rudimentary and lacks colonization
by pro T cells, are not completely devoid of lymphocytes
bearing T cell markers (3). nu/nu mice exhibit a numeric T
cell defect and an oligoclonal T cell repertoire (4) that is rich
in cells expressing products of "forbidden" TCR VO gene
families, e.g., VO genes normally deleted intrathymically due
to their autoreactivity with self minor lymphocyte stimulating
(Mls)t antigens (VO3 in BALB/c and C3H/HeN mice) or
'Abbreviations used in this paper. h, human; 11,2-VV, interleukin 2 vaccinia
virus; mls, minor lymphocyte stimulating; neoEk, neonatally thy-
mectomized; WT-VV, wild-type vaccinia virus.
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with self MHC-encoded EaEO products (VO11 in BALB/c,
C3H/HeN, and B10.D2 mice) (5-7). Similarly, neonatal
thymectomy results in an adult repertoire enriched in T cells
deleted in normal adult thymus (8, 9). Thus, cells expressing
V06 that are normally deleted in the MIS-12-expressing
DBA/2 strain and the potentially I-E-reactive V011 (in
[C57BL/6 x A/J]Fl and BALB/c mice) and VO5 (in
DBA/2 mice) that are normally deleted in I-E-expressing mice
augment after surgical removal of the thymus at day 3 (8,
9). In neonatally thymectomized (neoTk) BALB/c and DBA/2
mice T cells that escape clonal deletion are not functional,
i.e., they fail to proliferate in response to clonotypic V#-
specific antibodies (9) . However, functional inactivation of
cells bearing a forbidden TCR repertoire is not absolute, since
both thymectomized (C57BL/6 x A/J)Fi mice (8) and
aged BALB/c nu/nu mice exhibit signs of autoimmunity (10).
TCR-ci/g+ lymphocytes from athymic mice display func-
tional and phenotypical abnormalities ranging from decreased
TCR and CD3 density (11) to low Thy-1 expression, defec-
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Volume 173 June 1991 1323-1329tive lymphokine production (3), and abnormallyhigh amounts
of double-negative (CD4- CD8 - ) cells (7) .
Although it seems clear that selective expansion of for-
bidden clones occurs in athymic condition, either after sur-
gical thymectomy or in nude mouse models, it is unknown
whether extrathymic T cell maturation is triggered under
these conditions. Here, we report that neonatal thymectomy
leads to a surge of V011' T cells (normally deleted due to
their I-E reactivity) in the periphery of CBA/H mice and
entails a numeric defect in cells bearing pan T cell markers
(Thy-1, CD3) in peripheral lymphoid organs. Surprisingly,
however, it results in a selective expansion of T cells bearing
the immature CD3+CD4 - CD8- phenotype and expressing
products of the forbidden V011 gene family in the perito-
neal cavity. Using a human (h)IL2 vaccinia virus construct
as an autonomously replicating IIL2 releasing device, we were
able to induce conversion of these peritoneal cells to mature
CD4+ or CD8+ cells and to induce autoimmune manifesta-
tions in vivo. Moreover, cells from mice treated with 11,2
vaccinia virus acquired the capacity to proliferate in response
to anti-Vo11. These results suggest: (a) peritoneum is a site
for extrathymic T cell maturation or accumulation; (b) the
function of nonresponsive T cells may be triggered by IL2
in vivo; and (c) Ils2 may precipitate autoimmune disease in
athymic conditions.
Materials and Methods
Animalsand CellSuspensions.
￿
3-d-old CBA/H mice (TheJackson
Laboratory, Bar Harbor, ME) were anesthesized by hypothermia
and were thymectomized by the suction technique previously de-
scribed (12). Mice were killed by C02 inhalation at 6, 12, and 24
wk of life. Cell suspensions from bone marrow, spleen, and in-
guinal lymph nodes were prepared using standard techniques, and
peritoneal cells were obtained by washing the cavity with 10 ml
of chilled BSS-3% FCS, followed by two washings. In some ex-
periments, mice were injected intraperitoneally with 107 plaque
forming unitsofrIL2 vaccinia virus (IL2--W) (13) orwild-type vac-
cinia virus (WT-VV) starting from 6 wk of age. Treatment was
repeated three times in 2-wk intervals. At necropsy, at 12 wk of
age, various organs were removed and subjected to hematoxylin
eosin histology.
ELISAs.
￿
Sera were tested for the presence of anti-DNA anti-
bodies and rheumatoid factors following standard ELISA protocols
(14). Briefly, polyvinylchloride microtiter plates (Dynatech, Alex-
andria, VA) were coated by overnight incubation (4°C) with sheared
salmon sperm DNA (5 Fig/ml) or pools of IgG2a or IgG1 mAbs
(10 hg/ml) in 50 mM PBS (pH 7.4), followed by blocking with
PBS containing 1% gelatin. Plates were incubated at room tem-
perature for 2 h with serial dilutions of mouse sera (in PBS + 1%
gelatin), washed with peroxidase-labeled goat anti-mouse Ig, and
developed using o-phenylendiamine as substrate. Optical density
was measured at 450 nM.
Fluorocytometric Analysis.
￿
mAbs directed against CD3 (clone
145.01), CD4 (GK1.5; Becton Dickinson & Co., Mountain View,
CA), CD5 (537.3), CD8 (H02.2), Thy-1.2 (30-H12), V#8 (F23.1,
specific for Vy8.1, V08.2, and V08.3; reference 15), V,911 (RR3;
reference 16), and Vp6 (44.22.1; reference 17) were either FITC
labeled or used as biotin-conjugated reagents anddevelopedby means
of streptavidin-PE (Becton Dickinson & Co.). Cells were stained
following standard protocols and fluorescence was measured using
1324 Interleukin 2 Promotes Autoimmunity in Athymic Mice
the Epics Profile flow cytometer (Coulter Electronics, Hialeah, FL).
Background values were defined by using isotype-matched irrele-
vant antibodies as negative controls.
T Cell Proliferation Assays. Flat-bottomed microtiter wells
(Nunc, Kamstrup, Denmark) were incubated for 3 h at 37°C with
100 P.1 of PBS containing 0.2, 2, or 20 Wg/ml 145.C11 (aCD3),
V,B8 (F23.1), RR3 (ceVs11), or KJ23a (uVs17a, reference 18) and
then washed three times before use. 105 peritoneal exudate cells
or splenocytes were incubated for 3 d in 200 ul in RPMI 1640
supplemented with 10% FCS, 50 uM 2-ME, 10 mM Hepes, 200
MM r.-glutamine, 10 U/ml penicillin, and 100 wg/ml streptomycin,
and 10 U/mlrhIL2(Hoffinann-La Roche, Basel, Switzerland). Cells
were harvested after an 18-h pulselabel with 1 pCi of ['H]thymi-
dine (Amersham, London, UK) .
Results and Discussion
As evident from Table 1, relative and absolute T cell numbers
were reduced after thymectomy both in spleen and in lymph
node, a phenomenon associated with a diminution of the
CD4/CD8 ratio, since depletion was more pronounced among
the CD4+ subset. The decrease in splenic T cells was man-
ifest at the relative level, whereas lymph nodes displayed only
a mild relative T lymphopenia, but were greatly reduced in
size. In contrast to the T cell depletion observed in periph-
eral lymphoid organs, among cells recovered from the peri-
toneal cavity ofneoTxanimals, the relative and absolute number
oflymphocytes bearing the Thy-1 or CD3 pan-T cell markers
was significantly increased at 6 and 12 wk ofage, but returned
to control values at 4 mo (Table 1). This transient elevation
of peritoneal T cell numbers was accompanied by the pres-
ence of a high portion of cells exhibiting the CD3+CD4 -
CD8 - phenotype, i.e., a cell type that is practically absent
in the peritoneum of control mice and that is found at very
low percentages (<1%) in spleens or lymph nodes of nedTk
or control CBA/H mice (Table 1). This double-negative
phenotype has been associated with autoimmune phenomena
in mice affected by the lpr, gld (19), and nu mutations (7),
as well as in individuals afflicted with systemic autoaggres-
sive diseases (20), and may either represent an immature stage
of T cell maturation preceding acquisition of the accessory
molecules CD4 and/or CD8 (1) or, alternatively, may derive
from a "loss pathway" where accessory molecules are down-
regulated on autoreactive T cells that have escaped negative
selection (19, 21, 22), thus exhibiting an antigen-unresponsive,
anergic behavior. In this context, it may be noteworthy that
the pleuroperitoneal cavity has already been reported to rep-
resent the primordial differentiation site of coelomic CD5+
B lymphocytes (23) and, therefore, is likely to possess a lym-
phocytotrophic nature.
In accordance with previous reports (5-10), thymectomy
results in the expression of forbidden TCR gene products
in peripheral lymphoid organs, specifically V011, i.e., a Vs
gene product that is clonally deleted in euthymic CBA/H
mice due to its high reactivity with yet unidentified non-
MHC antigens presented by class II I-E molecules (15, 24).
Neonatal thymectomy has been equally reported to result in
the abolition of clonal deletion of Vo11 in (C57BL/6 x
A/J)Fl and BALB/c mice (8, 9) . In contrast, the percentageTable 1.
￿
Effect of Neonatal Thymectomy on the Frequency ofT Cells in Peripheral Lymphoid Organs
Cells derived from peritoneum, spleen, or lymph nodes from neoTx or sham-treated CBA/H mice were analyzed by immunocytofluoremetry as
described in Materials andMethods, andresults were expressed as percentage of stained cells. In each case, at least sixanimals were analyzed. Variances
were <10% for cytofluorometric data and <15% for determinations of viable cell numbers.
" Arrows indicate significant differences between thymectomized and respective control animals (p < 0.01, unpaired student's t test).
t The percentage of double negatives among CD3+ cells was determined by double staining.
of cells expressing Vs11 gene products does not augment in
neoTx DBA/2 mice (9), although Vo11 T cells should be as
potentially self-reactive as in the otherI-E-expressing strains
studied, a fact that is not at present understood. In neoTx
CBA/H mice, V#11 attained a level of 25.1 ± 4.7% (mean
± SEM; n = 6) among CD3 + cells in the spleen and 42.2
± 7.8% in the peritoneum, i.e., 8-10-fold higher than in
sham-treated controls, and remained constant throughout the
period examined (6-24 wk of age), whereas control V,6
products (VS6, V#8) are expressed at near to normal levels
(Table 2) . We have no explanation for the twofold increase
in Vs6+ cells among splenic CD3+ cells, which was not ob-
served in peritoneum. In spite of the high expression of a
potentially autoreactive (Vo11+) TCR, neoTx CBA/H mice
did not display any clinical (arthritis, proteinuria, cutaneous
ulcera), serological (rheumatoid factor, anti-DNA antibodies),
or histopathological signs of autoimmune disease (vide infra).
This absence of autoaggression in spite of failure of clonal
deletion is thought to be due to the preservation of autotoler-
ance by clonal anergy, since nondeleted V,911+ cells from
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neoTx I-E-bearing mice fail to proliferate in response to I-E+
stimulator cells or immobilized antiVo11 (9).
Intraperitoneal inoculation of a rhllr2 vaccinia virus con-
struct, which induces production of high levels (up to 20
U/ml in serum) of hIL2 around day 10 after infection (13),
resulted in appearance ofaccessory molecules (CD4 or CD8)
on the peritoneal T cell population (Fig. 1) without inducing
significant changes in the TCR repertoire expressed by these
cells. The decrease in CD3+CD4-CD8- cells is not due to
an outgrowth ofpre-existing single-positive T cells prolifer-
ating with IL2, since no significant increase of single-positive
cells were found in sham-operated CBA/H mice treated with
hIL2VV (data not shown). It remains elusive whether IL2
stimulates de novo expression of CD4 and/or CD8 on an
immature double-negative population or induces restitutio
ad integrum of cells that have lost their accessory molecules
during an anergization process. A dailyfollow-up ofthe pheno-
type ofperitoneal cells changing theirantigenic make-up after
the application of hIIr2VV failed to detect double-positive
cells (CD4+CD8+ ; Fig. 1 and data not shown), thus
Organ 6 wk
Thymectomy
12 wk
Percentage
24 wk
of cells after:
6 wk
Sham treatment
12 wk 24 wk
Peritoneum Cell yield ( x 10 -5) 33" 29t 24 15 18 20
Thy-1+ 18t 20t 16 4 14 15
CD3+ 17t 18} 14 4 12 14
CD4+ 4 6 7 3 6 8
CD8+ <0.5 3 7 <0.5 4 4
CD3*CD4-CD8-t 71t 39t 2 <0.5 <0.5 <0.5
Spleen Cell yield ( x 10-6) 40 60 87 42 83 125
Thy-1+ 15' 101 26' 47 50 50
CD3' 74 8t 22 45 43 45
CD4' 34 4i 20 30 30 32
CD8' 4+ 44 10 16 16 12
CD3`CD4-CD8- <0.5 <0.5 <0.5 <0.5 <0.5 <0.5
Lymph node Cell yield (x 10-6) V 24 44 11 25 23
Thy-1+ 514 47' 55' 87 85 90
CD3' 46' 45' 60 82 81 86
CD4+ & 21' 29' 60 57 43
CD8* 28 25 33 30 26 30
CD3+CD4-CD8- <0.5 <0.5 <0.5 <0.5 <0.5 <0.5Table 2.
￿
Effect of Neonatal Thymectomy on the TCR Repertoire Expressed by Peripheral T Cells
Cells derived from peritoneum or spleen from neoTx or sham-treated CBA/H mice were subjected to two-color cytofluorometric analysis, and results
were expressed as percentage of cells expressing products of a particular TCR Vs gene family (biotin-labeled mAbs F23.1, RR3, and 44.22.1 spe-
cific for products of the V#e , Vd6, and V611 gene families, respectively) among CD3 (FITC-labeled) cells (Table 1) .
Arrows indicate significant differences between thymectornized and respective control animals (p <0.01, unpaired student's t test) . In no instance
were significant differences in the median fluorescence intensity detected for Vs gene expression .
Figure 1 .
￿
Effect of rhI1r2 vaccinia virus on peripheral T cells of neoTx CBA/H mice . NedEx CBA/H mice were treated by intraperitoneal injection
of rIl.2VV or WT-VV, as described in Materials and Methods, followed by assessment of the frequency ofCD3*CD4-CD8 - (double negatives)
andCD3 "CD4*/CD8* cells in the peritoneum (A) . The ratio between CD4*CD8- and CD4-CD8' cells did not change significantly upon IL2-
VV treatment . Moreover, the proliferation of peritoneal and splenic T cells in response to otCD3, W08, WS11, anduV617a was assessed (B) . Values
are as mean values ± SEM, and background values (<2 x 103 cpm) were subtracted . Asterisks mark significant differences (p < 0.01; unpaired stu-
dent's t test) between the two groups of animals. Wp1% may be considered as negative control since CBA/H mice express the V#176 allele (18) .
Results are shown for an antibody concentration of 20 hg/ml used for coating microtiter plates, and analogous results were obtained with lower antibody
concentrations (data not shown) . The percentage of Vs8' and Vs11* cells among CD3* T cells did not vary significantly betweenWT-VV (28 ±
6% Vs8" and 35 t 7% Vs11' in peritoneum ; 34 ± 6% V68* and 22 ± 5% VOW in spleen) and IIJ2VVtreated animals (27 *_ 4% V08+ and
39 ± 5% VOW in peritoneum; 32 ± 5 Vs8* ; 26 ± 4VOW T cells in spleen) .
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Percentage (n * = 6) among CD3 cells after :
Thymectomy Sham treatment
VQ gene
Organ family 6 wk 12 wk 24 wk 6 wk 12 wk 24 wk
± SEM
Peritoneum V06 9.8 ± 1.7 9 .3 ± 1 .6 8 .7 ± 1 .5 14.9 ± 1.6 13 .5 ± 1.5 14.7 ± 1.3
V#8 35 .2 ± 6.2 33 .1 ± 6.3 34.7 ± 6.7 29.7 ± 3.5 28.4 ± 3.2 29.3 ± 3.5
V#11 42.2 ± 7.81" 40.5 ± 7 .21 37 .2 ± 6.71 5 .1 ± 0.5 4.7 ± 0.5 4.3 ± 0.4
Spleen V06 15 .2 ± 3.01 14.7 ± 3 .11 15 .1 ± 2.91 6 .5 ± 0.6 7 .2 ± 0.5 6.8 ± 0.6
Vg8 37.6 ± 7.3 35.3 ± 6 .8 35 .7 ± 7.1 38 .1 ± 3.2 37 .5 ± 3.1 38 .3 ± 3.5
VO11 24.7 ± 4.51 25 .1 ± 4.71 24.3 ± 4.31 2 .6 ± 0.3 3 .1 ± 0.8 2.3 ± 0.2providing indirect evidence in favor of the second possibility.
Intermediate affinity IL-2 receptors (p75, heavy chain) have
been detected both on immature thymocytes (25) as well as
on abnormalT cells ofMRLIMp-1pr/1pr mice (26), suggesting
that 11,2 may exert direct effects on double-negative T cells.
IL2 has been shown to trigger the maturation of pre- and
intrathymic T cell precursors in vitro where it drives double-
negative cells into the double-positive stage (25) . On the other
hand, IL2 restores the capacity of anergic T lymphocytes,
i .e ., cells that have not been clonally deleted but functionally
paralyzed, to proliferate in response to antigenic stimuli (24,
27-29) . Accordingly, nondeleted V,s11+ cells of IL2VV
treated animals acquire the capacity ofproliferating with anti-
Vs11 antibody, whereas cells from control animals fail to
mount a significant response (Fig. 1) . This is in contrast with
the finding by Jones et al. (9) that nondeleted V,611 + cells
from neoTx I-E-bearing mice fail to proliferate in response
to antiVo11 or appropriate stimulator cells, even when ex-
posed during a short term (3 d) culture to IL2 . Nonetheless,
the very different experimental design (in vitro vs . in vivo)
and the different duration of IL2 treatment (6 wk vs . 3 d)
may explain this discrepancy .
Both CD4+ and CD8+ T cells expressing Vs11 receptors
are known to respond to I-E antigens in vivo (30), and in-
duction ofCD4 on double-negative splenicT cells by in vitro
culture with Con A has been known to induce autoreactive
behavior ofT cells that provide help to autoimmuneB cells
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Figure 2 .
￿
Autoimmune manifestations
induced by 11,2 in neoTx CBA/H mice.
CBA/H mice, either sham treated or
thymectomized (Tx) 3 d after birth, were
treated by intraperitoneal injection of 10 7
plaque forming units ofrIL2-VV orWT
VV starting from 6wk ofage. Treatment
was repeated three times in 2-wk intervals
followed by necropsy and assessment of
serum autoantibody concentrations at 12
wk ofage (A) . Concentrations ofrheuma-
toid factors directed against lgG1 or IgG2a
(mean values ± SEM; n = 6 for each
group) . (B) Serum concentrations ofanti-
dsDNA ofthe IgM or IgG isotypes as de-
termined by ELISA at a 200-fold dilution
ofsera. Asterisks indicate significant differ-
ences between Tx/I1,2VV treated animals
and control groups (p < 0.01 ; Student's t
test) . Total immunoglobulin levels were not
affected by IIL2VV or WT-VV treatment .
(C) HE staining of a kidney from sham-
treatedCBA/Hmice treated with 11,2VV;
(D) orfrom a neoTx individual treated with
wild-type virus. (E) Representative sample
from neoTx animals treated with 11,2-VV.
Note the interstitial mononuclear infiltrate
visible only in E .
(31) . It therefore is tempting to speculate that the induction
of phenotypically mature (CD4+/CD8+) and functionally
competent T cells bearing products of this potentially self-
reactive TCR V0 gene family may be functionally linked to
the development ofautoimmune phenomena . IL2VV, not
WT-VV, provokes the production ofDNA autoantibodies
and rheumatoid factors, as well as an interstitial nephritis,
in neoTx CBA/H mice, but fails to do so in euthymic con-
trols (Fig. 2) . This observation supports the notion that IL2
may precipitate autoimmune diseases (32) . Accordingly, ap-
plication ofIL2 receptor antibodies prevents the development
of virtually any autoimmune disease investigated in this re-
spect, and rIL2 frequently induces autoimmune lesions in
patients (33) . Inoculation of the hIL2VV construct used in
this report induces overt autoimmunity in neoTx CBA/H
animals, as well as in youngBALB/c nu/nu and C57B1/6 nulnu
mice (Gutierrez-Ramos, Moreno de Albor£n, and MartinezA,
manuscript in preparation) . No effect is observed in CBA/H
mice thymectomized at 3 mo of age. In contrast, the same
treatment ameliorates systemic lupus erythematosus developing
in MRL/Mp Iprllpr mice (13) . This discrepancy either reflects
a pleiotropic involvement of the IL2/IL2 receptor system
in the cascade of events leading to autoimmune disease or,
alternatively, may be ascribed to the very different etiology
of autoaggression in distinct animal models. Thus, athymia
with the consequent perturbations in T lymphocyte reper-
toire, imbalance in distinct T cell populations, suppressor/helper ratios, and deficient "lymphokine sink" (34) could pre-
dispose to 11,2-induced autoimmunity, whereas presence of
a thymus may preclude such an 1172 effect. In this context,
it is worthwhile to mention that Ih2 actually induces thymic
hyperplasia in MRL/Mp lpr/lpr mice, which normally are
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